A thriving biotechcontributing to

A better wayto feed the planet

A PLANET HUNGRY FOR FOOD AND PERFORMANCE

The world needs more food

People want better foodHealthy

Safe

Responsible

Exper ts say that we must double the food supply by 2050 in order to feed humanity. However, the planet cannot support doubling the land al located to crops and animal grazing. There just aren’t enough resources.

The solution is to improve the production process: increase yields, reduce waste, improve eff iciency, f ind new and better food sources, and increase the nutr it ional value of existing ones.

This is what Prevtec is out to do.

You cannot have missed the growing appetite for healthier food. While consumers in developed countr ies cal l for less fat , less sugar, less salt , less additives of al l sor ts, poorer countr ies str ive for a more balanced and nourishing diet . And as they get r icher, they consume more meat, pushing the global meat demand to new heights. Prevtec ’s focus is to help produce more high quality meat.

Food scandals have ruined more than one appetite in recent years. When the culpr it is not the omnipresent E. coli causing ser ious health issues, it is the remedies themselves, star t ing with the overuse of antibiotics. Prevtec helps improve food safety by f ighting diseases with safe alternatives to drugs.

Food production in general, and meat production especial ly, are often cr it icized for using huge amount of resources and producing vast amounts of waste that fur ther burden the environment. By improving the eff iciency of the production process, we consume fewer resources and generate less waste, and at the same time supply more food. This is exactly what Prevtec is work ing on.

Source : Jeff Simmons, Elanco

A PLANET HUNGRY FOR FOOD AND PERFORMANCE

Producers strive for performance

The industry requires innovation

Productivity

Efficiency

Profitability

The challenge to feed humanity fuels innovation and investment at al l levels of the food industr y. Fundamental changes are in store and some of them are dr iven from outside the industr y itself : consumer activism and government regulation being only two examples of external forces at work .

The animal health industr y has r isen to the challenge and is star ting to adapt its practices and its products to the new market. Recently, major pharmas have launched massive outsourcing programs to f ind new alternatives to their tradit ional drugs, and especial ly the controversial antibiotics.

Prevtec pr ides itself on offer ing effective medicines that are the best alternatives to antibiotics.

The most obvious way to produce more abundant and more affordable food is to improve productivity. In animal farming, this means diminishing mortal ity rate, s ickness prevalence and severity, increasing feed conversion and enhancing growth. I f this reads l ike a l ist of Prevtec ’s products benefits, that ’s no accident.

Producers are mak ing ever y effor t to improve the eff iciency of their operations. Competit ion and rationalization favour optimal use of human and physical resources, streamlined procedures and protocols, and rapid turnover. Prevtec contr ibutes to such improvements, for example with solutions that reduce animal handling, contr ibute to more uniform growth, and help diagnose problems ear ly.

Competit ion, consumer demand and government regulation are forcing the industr y to change, requir ing heavy investments. Producers are under a lot of pressure to balance cost increases with productivity gains in order to maintain profitabil ity. Prevtec targets technologies that offer such advantages and markets products that are economically cost-effective.

75%

2020

Drugs

Biologics

2010

25%

67% 33%

PREVTEC:A GLOBAL ANIMAL HEALTH BIOTECH

Innovative technologies

Branded products

High-value

Biologics

Timely

Prevtec has pulled off a somewhat unique feat in the industr y. We know of no other biotech that has achieved our global posit ioning and sti l l maintains the level of control we have on the marketing and distr ibution of our products.

Prevtec ’s f irst product, Coliprotec®, is now marketed on two continents. We have international agreements for the sale of several of our products in Europe, Asia and Russia. Two of the largest animal health companies in the world are sel l ing our products under Prevtec ’s own name in a co-branding agreement. Fur thermore, in ever y countr y where our products are approved, we have the exclusive ownership and control of the marketing authorization.

Prevtec ’s technologies offer solutions that have signif icant economic impacts on animal farming. Our vaccines target diseases that are costly to producers, such as post-weaning diarrhea, edema disease or streptococcus suis in pig production, avian colibacil losis and salmonellosis. Our por tfol io includes such things as antibodies against hamburger disease in bovine. We develop feed additives that boost productivity in responsible, healthy and sustainable approaches.

We don’t do antibiotics. More importantly, we offer a way for producer to eff iciently reduce their use. I t is always good practice to l imit the use of antibiotics, and in a growing number of countr ies antibiotics are now being banned if used only as prevention measures or as growth promoters. Many of our technologies are cost-effective alternatives to antibiotics used as medication or growth factor.

Our technologies are unique and they address painful problems in food production. No wonder large animal health companies are so interested in our offer ing. Our business model cal ls for a constant quest for high-interest , high-value opportunities that we can then leverage profitably to innovation-hungr y organizations look ing to f i l l their product por tfol io.

PREVTEC:A GLOBAL ANIMAL HEALTH BIOTECH

International standing

High-value expertisePrevtec ’s success rests upon a ver y special mix of three f ields of exper tise and three business attitudes. We blend veter inar y, regulator y and management exper tise with entrepreneurship, par tnering and innovation. This unique combination has al lowed Prevtec ’s team to build a far-reaching presence in the global market in only a few years. Constantly acquir ing new talents as we grow, we have achieved industr y recognition for our abil ity to foster R&D, transfer technology to industr y and l icense products worldwide.

Prevtec has off ices on 4 continents, either directly or through subsidiar ies and representative off ices. Our Coliprotec® vaccine is now sold in Canada and Brazi l , while regulator y approval has been granted or f i led for in 5 other jur isdictions, including Europe’s 23 countr ies. Our technical documentation is avai lable in English, French, Por tuguese, Russian and Chinese. We have patents recognised or pending in 10 countr ies and our trademarks are registered in 15 countr ies.

Throughout the world, Prevtec has developed a network of par tners and resources of great value. We have direct access to C-suite executives of the largest animal health organizations on the planet, world-class research organizations (CRO) and manufacturing faci l it ies (CMO). We and our staff belong to global networks of researchers, scientists and academics.

Business modelOur business model is based on a unique mix of innovation and par tnership strategies, implemented throughout the product development and marketing stages.

We partner with scientists, academics and research organizations to discover and assess new technologies. We partner with universities and government agencies to further and finance research and development. Once our technologies achieve the proof of concept, we partner with contract research organizations (CROs) and contract manufacturing organizations (CMOs) to transform the technology into a winning commercial product. Finally, worldwide distribution is also achieved through international partnerships with animal health companies that are chosen for their strength in the various regional markets we target.

However, Prevtec always keeps the lead over the development process, from scientif ic development to business development. We especial ly pr ide ourselves on maintaining ownership of the intel lectual proper ty related to our technologies and control of the regulator y cer tif ications related to our products (also cal led marketing authorizations or l icenses in var ious countr ies) .

Scoutingfor news technologies

Researchby researcher

Researchby CRO

Sale bydistributor

Regulatoryprocess

Authorization

Strategic assetsTrack record

Technologies

People

Prevtec has a proven abil ity in transforming technologies into products, al l the way from the lab to the global market. We have done what many industr y veterans thought could not be done and we wil l soon hold the market authorization for our products in more than 12 countr ies over 4 continents.

We have a deep knowledge of farming issues, animal health problems, and their potential solutions. By constantly scouting for promising technologies through our international network and often acting faster than the big pharmas, we have gathered a valuable por tfol io of technologies and products supported by a strong IP strategy.

We are a small and dynamic team, backed by solid par tners. Our shareholders have invested more than $10 mil l ion to support our expansion. We are pr ivi leged to count two of the top animal health companies in the world as our distr ibutors and beyond our par tners, we reach a vast network of scientif ic and business resources in the Americas, Europe and Asia.

2 0 0 1

2 0 0 5 2 0 0 6 2 0 0 7 2 0 0 8Te c h n o l o g y t r a n s f e r

Co l i p ro t e c ® s o l d i n Ca n a d aCe r t i f i c a t i o n i n Ca n a d a

P re v t e c d o B r a z i l2 0 0 92 0 1 0

JOINING FORCESTO HELP FEED THE WORLD

Our network

Milestones

R&D

Production

Distribution

Finance

E l a n c o a s d i s t r i b u t o r

Ce r t i f i c a t i o n i n Eu ro p e

N e w p ro d u c t s o n t h e m a r ke t

Ce r t i f i c a t i o n i n B r a z i l

Vi r b a c a s d i s t r i b u t o r

S a l e s i n n e w m a r ke t s

2 0 1 12 0 1 2

2 0 1 32 0 1 4

2 0 1 5

2 0 1 6

2 0 1 7

JOINING FORCESTO HELP FEED THE WORLD

GROUPE GESTIONJAFACOGESTION ET FINANCEMENT DE P.M.E.

INC.

Prevtec microbia Inc.Head O ffice

1250 René -Lévesque Blvd. West , 38th FloorMontréal, Canada+1 (514) 905-0401

Prevtec microbia Inc.R&D and Operations Center

St-Hyacinthe, Canada+1 (450) 774-7000

Prevtec Microbia do Brazil LtdaToledo, Brazi l

+55 (41) 8828 5610

Prevtec Microbia GmbH Munich, Germany

+49-89-580 082 444

Barcelona, Spain+34 935 543 040

Prevtec Microbia HK Limited Hong Kong

+862 5646 8551

Prevtec in Mainland ChinaBei j ing, China

+86 147 1433 8551

© Prevtec microbia 2014 (141009)